These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8479006)

  • 1. Urinary excretion of metals during treatment with D-penicillamine and 2-mercaptopropionylglycine in normal and cystinuric dogs.
    Hoppe A; Denneberg T; Frank A; Kågedals B; Petersson LR
    J Vet Pharmacol Ther; 1993 Mar; 16(1):93-102. PubMed ID: 8479006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion.
    Hoppe A; Denneberg T; Jeppsson JO; Kågedal B
    Br Vet J; 1993; 149(3):235-51. PubMed ID: 8334506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.
    Hoppe A; Denneberg T; Kågedal B
    Am J Vet Res; 1988 Jun; 49(6):923-8. PubMed ID: 3400930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of amino acids in normal and cystinuric dogs.
    Hoppe A; Denneberg T; Jeppsson JO; Kågedal B
    Br Vet J; 1993; 149(3):253-68. PubMed ID: 8334507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
    Harbar JA; Cusworth DC; Lawes LC; Wrong OM
    J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of 2-mercaptopropionylglycine administered intravenously and orally in dogs.
    Hoppe A; Denneberg T; Emanuelsson BM; Kågedal B; Lindgren S
    J Vet Pharmacol Ther; 1991 Dec; 14(4):374-84. PubMed ID: 1774814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystinuria in the dog: clinical studies during 14 years of medical treatment.
    Hoppe A; Denneberg T
    J Vet Intern Med; 2001; 15(4):361-7. PubMed ID: 11467594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.
    Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV
    J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cystinuria with alpha-mercaptopropionylglycine.
    Johansen K; Gammelgård PA; Jørgensen FS
    Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
    Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS
    J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of urinary carnitine and taurine excretion in 5 cystinuric dogs with carnitine and taurine deficiency.
    Sanderson SL; Osborne CA; Lulich JP; Bartges JW; Pierpont ME; Ogburn PN; Koehler LA; Swanson LL; Bird KA; Ulrich LK
    J Vet Intern Med; 2001; 15(2):94-100. PubMed ID: 11300604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria.
    Parvex P; Rozen R; Dziarmaga A; Goodyer P
    Mol Genet Metab; 2003 Dec; 80(4):419-25. PubMed ID: 14654355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients.
    Mårtensson J; Denneberg T; Lindell A; Textorius O
    Kidney Int; 1990 Jan; 37(1):143-9. PubMed ID: 2299801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sodium intake on cystinuria with and without tiopronin treatment.
    Lindell A; Denneberg T; Edholm E; Jeppsson JO
    Nephron; 1995; 71(4):407-15. PubMed ID: 8587620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
    Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
    Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillamine in canine cystinuria.
    Frimpter GW; Thouin P; Ewalds BH
    J Am Vet Med Assoc; 1967 Oct; 151(8):1084-6. PubMed ID: 6069499
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment of cystinuria and cystine lithiasis with alpha-mercaptopropionylglycine. Apropos of 40 patients].
    Giannakopoulos X; Kalfakakou V; Tsoumanis P; Karkabounas S; Giannakis D; Chambilomatis P; Evangelou A; Kallistratos G
    J Urol (Paris); 1994; 100(3):129-34. PubMed ID: 7836789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term outcome of cystinuria in Japan.
    Akakura K; Egoshi K; Ueda T; Nozumi K; Kotake T; Masai M; Ito H
    Urol Int; 1998; 61(2):86-9. PubMed ID: 9873246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.